oxaprozin
Generic: oxaprozin
Labeler: direct_rxDrug Facts
Product Profile
Brand Name
oxaprozin
Generic Name
oxaprozin
Labeler
direct_rx
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
oxaprozin 600 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
72189-595
Product ID
72189-595_284ce161-0a4b-8999-e063-6394a90aa60a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075855
Listing Expiration
2026-12-31
Marketing Start
2024-12-02
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72189595
Hyphenated Format
72189-595
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxaprozin (source: ndc)
Generic Name
oxaprozin (source: ndc)
Application Number
ANDA075855 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 600 mg/1
Packaging
- 60 TABLET, FILM COATED in 1 BOTTLE (72189-595-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "284ce161-0a4b-8999-e063-6394a90aa60a", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["284ce161-0a4a-8999-e063-6394a90aa60a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (72189-595-60)", "package_ndc": "72189-595-60", "marketing_start_date": "20241202"}], "brand_name": "Oxaprozin", "product_id": "72189-595_284ce161-0a4b-8999-e063-6394a90aa60a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "72189-595", "generic_name": "Oxaprozin", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075855", "marketing_category": "ANDA", "marketing_start_date": "20241202", "listing_expiration_date": "20261231"}